MG Abrignani, A Lombardo, A Braschi… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Aspirin, other antiplatelet agents, and anticoagulant drugs are used across a wide spectrum of cardiovascular and cerebrovascular diseases. A concomitant proton pump inhibitor (PPI) …
J Dalal, AL Dutta, J Hiremath, SS Iyengar… - Cardiology and …, 2023 - Springer
This manuscript aims to critically evaluate the current evidence regarding adverse cardiovascular effects associated with proton pump inhibitors (PPIs) in patients with …
Uses of real-world data in drug safety and effectiveness studies are often challenged by various sources of bias. We undertook a systematic search of the published literature …
A Lanas-Gimeno, Á Lanas - Expert Opinion on Drug Safety, 2024 - Taylor & Francis
ABSTRACT Introduction Proton pump inhibitors (PPIs) rank among the most frequently prescribed medications to treat acid-related diseases. Mounting concerns surround the …
Purpose The increased use of proton pump inhibitors (PPIs) in the elderly has raised concerns about potential severe adverse effects. Our systematic review investigated the …
This manuscript aims to critically evaluate the current evidence regarding adverse cardiovascular effects associated with proton pump inhibitors (PPIs) in patients with …